Ilkari Expands European Sovereign Infrastructure Operations With Integration of DC North in Croatia
Expansion strengthens Ilkari’s multi-region sovereign infrastructure footprint with EU-based operational capacity, DORA-aligned resilience and sovereign cloud... Read more.
SkyDrive Reaches 100km/h Milestone
Data from Stable High-Speed Flight Supports Design Validity and Progress Towards Certification and Commercialization TOYOTA, Japan–(BUSINESS WIRE)–#FlyingCar–SkyDrive... Read more.
SkyDrive Reaches 100km/h Milestone
Data from Stable High-Speed Flight Supports Design Validity and Progress Towards Certification and Commercialization TOYOTA, Japan–(BUSINESS WIRE)–#FlyingCar–SkyDrive... Read more.
Tigo Energy Predict+ Forecasting Platform Helps YASNO Keep Energy Flowing in Ukraine
Advanced energy prediction platform, Predict+, enables Ukrainian utility to better maintain grid service through demand surges, highly variable weather, and infrastructure... Read more.
Tigo Energy Predict+ Forecasting Platform Helps YASNO Keep Energy Flowing in Ukraine
Advanced energy prediction platform, Predict+, enables Ukrainian utility to better maintain grid service through demand surges, highly variable weather, and infrastructure... Read more.
ABBYY Ascend DevCon Returns to Bengaluru July 22-23 to Spotlight the Next Wave of Enterprise Automation Powered by Document AI and LLMs
BENGALURU, India–(BUSINESS WIRE)–#ABBYY—ABBYY today announced that its developer conference (DevCon) is returning to Bengaluru, India, on July... Read more.
Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering
NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (Nasdaq: DFTX) (the “Company” or “Definium”), a late-stage clinical biopharmaceutical company... Read more.
Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering
NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (Nasdaq: DFTX) (the “Company” or “Definium”), a late-stage clinical biopharmaceutical company... Read more.
Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering
NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (Nasdaq: DFTX) (the “Company” or “Definium”), a late-stage clinical biopharmaceutical company... Read more.
Jacobs serving as technical advisor as construction begins on New York State’s $1.7B public health laboratory
New facility will strengthen New York’s disease detection and public health response DALLAS–(BUSINESS WIRE)–Jacobs (NYSE: J) is serving as the Dormitory... Read more.